Author

CL Van Den Berg

Observed name: CL Van den Berg

Institution: The University of Texas at Austin

Observed institutions: The University of Texas at San Antonio Health Science Center, The University of Texas at Austin

OpenAlex ID: A5110080677

Pharmacokinetic profile of recombination human insulin-like growth factor binding protein-1 in athymic mice

1996 · D Yee, CL Van Den Berg, et al. · Biomedicine & Pharmacotherapy · 10

Abstract P4-06-02: Systemic Deletion of c-Jun N-Terminal Kinase 1 or 2 Is Protective in Breast Cancer Bone Metastasis

2010 · A Nasrazadani, CL Van den Berg · Cancer Research · 1

Abstract P5-04-14: The covalent JNK inhibitor, JNK-IN-8, synergizes with lapatinib to cause cell death in basal-like breast cancer cell lines

2016 · ND Ebelt, CL Van Den Berg · Cancer Research

Abstract P6-04-17: The irreversible c-Jun N-terminal kinase (JNK) inhibitor, JNK-IN-8, sensitizes basal-like breast cancer cells to lapatinib

2013 · ND Ebelt, CL Van Den Berg · Cancer Research

P1-02-01: c-Jun N-Terminal Kinase 1 (JNK1) Inhibits Tumor Growth and Metastasis by Downregulating Epithelial to Mesenchymal Transition (EMT) and Stem Cell-Related Genes.

2011 · ND Ebelt, CL Van Den Berg · Cancer Research

Abstract P5-06-15: JNK2 Regulates Mammary Epithelial Cell Differentiation Through Inhibition of p53 and Notch-1 Expression

2010 · M Cantrell, ND Ebelt, et al. · Cancer Research

Works count: 6

Citation count: 11

H-index: 1

I10-index: 1